275 related articles for article (PubMed ID: 30746957)
1. Alagille syndrome: an uncommon cause of intrahepatic cholestasis in adults.
Zhang W; Zhao X; Huang J; Ou X; Jia J
Rev Esp Enferm Dig; 2019 Apr; 111(4):323-326. PubMed ID: 30746957
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic Novel Heterozygous Variant c.1076c>T p. (Ser359Phe) chr1: 120512166 in NOTCH2 Gene, Type 2 Alagille Syndrome Causing Neonatal Cholestasis: A Case Report.
Uddin MS; Al Fulayyih S; Al Denaini FF; Al Hatlani MM
Am J Case Rep; 2022 Oct; 23():e935840. PubMed ID: 36201396
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characterization of Alagille Syndrome in Patients with Cholestatic Liver Disease.
Semenova N; Kamenets E; Annenkova E; Marakhonov A; Gusarova E; Demina N; Guseva D; Anisimova I; Degtyareva A; Taran N; Strokova T; Zakharova E
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511516
[TBL] [Abstract][Full Text] [Related]
4. A case of Alagille syndrome presenting with chronic cholestasis in an adult.
Kim J; Yang B; Paik N; Choe YH; Paik YH
Clin Mol Hepatol; 2017 Sep; 23(3):260-264. PubMed ID: 28683534
[TBL] [Abstract][Full Text] [Related]
5. Not only Alagille syndrome. Syndromic paucity of interlobular bile ducts secondary to HNF1β deficiency: a case report and literature review.
Pinon M; Carboni M; Colavito D; Cisarò F; Peruzzi L; Pizzol A; Calosso G; David E; Calvo PL
Ital J Pediatr; 2019 Feb; 45(1):27. PubMed ID: 30791938
[TBL] [Abstract][Full Text] [Related]
6. Alagille syndrome caused by NOTCH2 mutation presented atypical pathological changes.
ShenTu Y; Mi X; Tang D; Jiang Y; Gao L; Ma X; Zhou B; Yang W; Shi J; Lan D; Chen G; Gong L
Clin Chim Acta; 2021 Oct; 521():258-263. PubMed ID: 34332988
[TBL] [Abstract][Full Text] [Related]
7. Alagille syndrome and risk for hepatocellular carcinoma: Need for increased surveillance in adults with mild liver phenotypes.
Schindler EA; Gilbert MA; Piccoli DA; Spinner NB; Krantz ID; Loomes KM
Am J Med Genet A; 2021 Mar; 185(3):719-731. PubMed ID: 33369123
[TBL] [Abstract][Full Text] [Related]
8. Alagille syndrome: pathogenesis, diagnosis and management.
Turnpenny PD; Ellard S
Eur J Hum Genet; 2012 Mar; 20(3):251-7. PubMed ID: 21934706
[TBL] [Abstract][Full Text] [Related]
9. Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.
Andersson ER; Chivukula IV; Hankeova S; Sjöqvist M; Tsoi YL; Ramsköld D; Masek J; Elmansuri A; Hoogendoorn A; Vazquez E; Storvall H; Netušilová J; Huch M; Fischler B; Ellis E; Contreras A; Nemeth A; Chien KC; Clevers H; Sandberg R; Bryja V; Lendahl U
Gastroenterology; 2018 Mar; 154(4):1080-1095. PubMed ID: 29162437
[TBL] [Abstract][Full Text] [Related]
10. New JAG1 Mutation Causing Alagille Syndrome Presenting With Severe Hypercholesterolemia: Case Report With Emphasis on Genetics and Lipid Abnormalities.
Hannoush ZC; Puerta H; Bauer MS; Goldberg RB
J Clin Endocrinol Metab; 2017 Feb; 102(2):350-353. PubMed ID: 27967296
[TBL] [Abstract][Full Text] [Related]
11. Alagille Syndrome.
Mitchell E; Gilbert M; Loomes KM
Clin Liver Dis; 2018 Nov; 22(4):625-641. PubMed ID: 30266153
[TBL] [Abstract][Full Text] [Related]
12. An Atypical Presentation of Alagille Syndrome.
Wu KY; Treece AL; Russo PA; Wen JW
Pediatr Dev Pathol; 2018; 21(1):79-83. PubMed ID: 29187043
[TBL] [Abstract][Full Text] [Related]
13. Premature senescence of the liver in Alagille patients.
Jannone G; de Magnée C; Tambucci R; Evraerts J; Ravau J; Najimi M; Sokal EM
PLoS One; 2023; 18(4):e0285019. PubMed ID: 37099537
[TBL] [Abstract][Full Text] [Related]
14. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency.
McCright B; Lozier J; Gridley T
Development; 2002 Feb; 129(4):1075-82. PubMed ID: 11861489
[TBL] [Abstract][Full Text] [Related]
15. Alagille-like syndrome with surprising karyotype: a case report.
Amimoto S; Ishii M; Tanaka K; Araki S; Kuwamura M; Suga S; Kondo E; Shibata E; Kusuhara K; Yoshino K
J Med Case Rep; 2023 Apr; 17(1):186. PubMed ID: 37101309
[TBL] [Abstract][Full Text] [Related]
16. Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome.
Adams JM; Huppert KA; Castro EC; Lopez MF; Niknejad N; Subramanian S; Zarrin-Khameh N; Finegold MJ; Huppert SS; Jafar-Nejad H
Hepatology; 2020 Apr; 71(4):1331-1349. PubMed ID: 31469182
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, outcomes, and genetic analysis in Korean children with Alagille syndrome.
Cho JM; Oh SH; Kim HJ; Kim JS; Kim KM; Kim GH; Yu E; Lee BH; Yoo HW
Pediatr Int; 2015 Aug; 57(4):552-7. PubMed ID: 25676721
[TBL] [Abstract][Full Text] [Related]
18. Alagille syndrome in a Vietnamese cohort: mutation analysis and assessment of facial features.
Lin HC; Le Hoang P; Hutchinson A; Chao G; Gerfen J; Loomes KM; Krantz I; Kamath BM; Spinner NB
Am J Med Genet A; 2012 May; 158A(5):1005-13. PubMed ID: 22488849
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic analysis in Chinese children with Alagille syndrome.
Chen Y; Sun M; Teng X
BMC Pediatr; 2022 Nov; 22(1):688. PubMed ID: 36447191
[TBL] [Abstract][Full Text] [Related]
20. Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome.
Deutsch GH; Sokol RJ; Stathos TH; Knisely AS
Pediatr Dev Pathol; 2001; 4(6):559-63. PubMed ID: 11826362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
